Skip to content

Comparison of Dialysis Therapies on Cognitive Function

Comparison of Dialysis Therapies on Cognitive Function

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT00597103
Enrollment
17
Registered
2008-01-17
Start date
2007-12-31
Completion date
2011-04-05
Last updated
2019-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Kidney Disease, End Stage Renal Disease

Keywords

Hemodialysis, Frequent Hemodialysis, Sleep Apnea, Restless Leg Syndrome, Cognitive Function

Brief summary

This study will evaluate the effects of more frequent dialysis on cognitive function including the assessment of sleep apnea and restless legs. Our hypothesis is that more frequent dialysis improves cognitive function and may have important implications on clinical care of ESRD patients and help to emphasize the need for treatments that will allow patients to live with dialysis rather than live for dialysis.

Interventions

OTHERCognitive Function Testing-10 Tests

Trailmaking A, Trailmaking B, Rey Auditory Verbal Learning, Letter Number Sequencing, Digit Symbol Substitution, Grooved Pegboard, Controlled Oral Word Association, Beck Depression Index, Feeling Thermometer, Modified Mini-Mental Status

OTHERSleep Assessment Testing

Sleep Assessment will be performed using an Actiwatch with subjects wearing the watch for 72 hours continuously

OTHERPeriodic Leg Movement Syndrome Assessment

Subjects will wear and Actiwatch on both legs for three consecutive nights.

Sponsors

Satellite Healthcare
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Diagnosis of ESRD * Age 18 years or greater * Ability to understand and a willingness to sign an informed consent statement and a Health Insurance Portability and Accountability Act of 1996 (HIPPA) authorization statement. * Expected survival of at least one year.

Exclusion criteria

* Documented non-compliance, defined as missing more than 10% of prescribed treatments during the month prior to the start of the study.

Design outcomes

Primary

MeasureTime frame
Distribution of cognitive function impairment in ESRD patients undergoing more frequent hemodialysisbaseline, 4 months and 12 months

Secondary

MeasureTime frame
Longitudinal analysis of cognitive function over time to test the hypothesis that more frequent hemodialysis contributes to delay in cognitive function impairmentbaseline, 4 months and 12 months
To test the hypothesis that nightly or daily hemodialysis treatment can ultimately be proven to be cost effective options by preserving cognitive function.12 months
Influence of cognitive function on survival.12 months

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026